Table 2.
eGFR | Proteinuria† | |||
---|---|---|---|---|
| ||||
Unadj | Fully Adj* | Unadj | Fully Adj* | |
20-HETE | 19.44 p=0.001 (8.26, 30.62) | 17.47 p=0.001 (7.37, 27.57) | 1.23 p=0.307 (0.83, 1.83) | 1.39 p=0.175 (0.86, 2.25) |
R2 0.05 | R2 0.31 | - | - | |
19-HETE | 12.56 p=0.028 (1.37, 23.75) | 60.68 p=0.005 (18.48, 102.88) | 0.98 p=0.960 (0.43, 2.21) | 22.12 p=0.003 (2.80, 175.05) |
R2 0.02 | R2 0.31 | - | - | |
15-HETE | 23.12 p=0.060 (−0.99, 47.22) | 7.97 p=0.710 (−34.34, 50.28) | 0.39 p=0.009 (0.19, 0.79) | 0.09 p=0.016 (0.01, 0.63) |
R2 0.02 | R2 0.24 | - | - | |
12-HETE | 3.40 p=0.141 (−1.14, 7.94) | −5.07 p=0.195 (−12.78, 2.63) | 0.95 p=0.572 (0.78, 1.14) | 1.06 p=0.720 (0.77, 1.45) |
R2 0.01 | R2 0.27 | - | - | |
8-HETE | 119.01 p<0.001 (57.03, 180.99) | 378.89 p=0.001 (160.01, 597.77) | 0.06 p=0.001 (0.01, 0.33) | 0.09 p=0.623 (0.00, 1293.61) |
R2 0.08 | R2 0.31 | - | - | |
14,15-diHETE | 9.00 p=0.002 (3.24, 14.77) | 9.83 p=0.062 (−0.50, 20.17) | 0.81 p=0.029 (0.67, 0.98) | 0.85 p=0.617 (0.45, 1.62) |
R2 0.04 | R2 0.28 | - | - | |
11,12-diHETE | 49.28 p<0.001 (22.27, 76.28) | 183.83 p<0.001 (87.50, 280.16) | 0.34 p=0.003 (0.17, 0.70) | 0.03 p=0.152 (0.00, 3.62) |
R2 0.07 | R2 0.32 | - | - | |
8,9-diHETE | 6.01 p<0.001 (3.96, 8.06) | 8.33 p<0.001 (5.56, 11.10) | 0.90 p<0.001 (0.85, 0.95) | 0.94 p=0.378 (0.81, 1.08) |
R2 0.13 | R2 0.40 | - | - | |
5,6-diHETE | 39.09 p<0.001 (22.08, 56.10) | 112.04 p<0.001 (74.27, 149.81) | 0.46 p<0.001 (0.31, 0.70) | 0.30 p=0.163 (0.05, 1.64) |
R2 0.09 | R2 0.39 | - | - |
For eGFR outcomes, beta coefficients (slope) with p-values, 95% confidence intervals, and r values are shown. For proteinuria outcomes, incidence rate ratios (IRR) are reported with p-values and 95% confidence intervals. Unadjusted and fully adjusted models are shown, with fully adjusted models having age, gender, BMI, systolic blood pressure, diastolic blood pressure, diabetes, lupus, and medications from table 3 used as confounders.